Clinical Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Reviews Online Annual Meeting Education Book
Cell Growth & Differentiation

(These articles have been accepted for this issue. Change is possible before publication.)
Receive this page by email each issue: [Sign up for eTOCs]

Future Table of Contents: Apr 15, 2008; 14 (8)

      Down Molecular Pathways
      Down Human Cancer Biology
      Down Imaging, Diagnosis, and Prognosis
      Down Cancer Therapy Clinical
      Down Cancer Therapy Preclinical
      Down Letters to Editor

Molecular PathwaysBack

Benjamin Braun et al.
Targeting Ras in Myeloid Leukemias

Human Cancer BiologyBack

Urszula Dougherty et al.
EGFR Controls Flat Dysplastic ACF Development and Colon Cancer Progression in the Rat Azoxymethane Model

Lin Jia et al.
Endometrial Glandular Dysplasia with Frequent p53 Gene Mutation: A Genetic Evidence Supporting its Precancer Nature for Endometrial Serous Carcinoma

Johannes Mayr et al.
Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma

Frank Speetjens et al.
Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients

Severine Tabone-Eglinger et al.
KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in Gastro-Intestinal Stromal Tumors (GISTs)

Imaging, Diagnosis, and PrognosisBack

Peter Brader et al.
E. coli Nissle 1917 fascilates tumor detection by PET and optical imaging

Richard Hubner et al.
Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention

Kazuhiko Ino et al.
Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival

Laleh Kamalian et al.
Increased expression of Id-family proteins in small cell lung cancer and its prognostic significance

Joo-Heon Kim et al.
Up-regulation of Peroxiredoxin 1 in Lung Cancer and Its Implication as Prognostic and Therapeutic Target

Kazuo Motoyama et al.
Clinical Significance of HMGA2 in Human Gastric Cancer and its Relationship to let-7 microRNA family

Hari Dhakal et al.
Vascularization in Primary Breast Carcinoma:its Prognostic Significance and Relationship with Tumor Cell Dissemination

Michiyo Yamada et al.
Amphiregulin is a promising prognostic marker for liver metastases of colorectal cancer

Robert Brown et al.
Detecting Genetic Signatures in Oligodendroglioma Non-Invasively Using MR

Yataro Daigo et al.
Activation of Placenta Specific Transcription Factor Distal-less Homeobox 5 Predicts Clinical Outcome in Primary Lung Cancer Patients

Carmen Marsit et al.
A genotype-phenotype examination of Cyclin D1 on risk and outcome of squamous cell carcinoma of the head and neck

Marsha Moses et al.
Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy

Noopur Raje et al.
Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw

Ina Pavlova et al.
Understanding the biological basis of autofluorescence imaging for oral cancer detection: High resolution fluorescence microscopy in viable tissue

Cancer Therapy ClinicalBack

Thomas Efferth et al.
Prediction of Broad Spectrum Resistance of Tumors towards Anti-Cancer Drugs

Sylvain Ladoire et al.
Pathological complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating Foxp3+ regulatory T cells.

Brian Shumway et al.
Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions.

Astrid van der Veldt et al.
Sunitinib for treatment of advanced renal cell cancer: primary tumor response

Steven Attia et al.
Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol (1a-hydroxyvitamin D2) in patients with metastatic, androgen-independent prostate cancer

Guido Marcucci et al.
A Phase I Biologic Study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase I, in Patients with High Risk Myelodysplasia and Acute Myeloid Leukemia

Cancer Therapy PreclinicalBack

Jingjing Luo et al.
Treatment of cancer with a novel dual targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene

Hajime Orita et al.
Inhibiting fatty acid synthase for chemoprevention of chemically induced lung tumors

Torsten Trowe et al.
EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated with Lapatinib Resistance and Neoplastic Transformation

Amit Verma et al.
Therapeutic Significance of Elevated Tissue Transglutaminase Expression in Pancreatic Cancer

Ralf Weichsel et al.
Profound inhibition of antigen-specific T cell effector functions by dasatinib

Julia Coppola et al.
Non-invasive imaging of apoptosis and its application in cancer therapeutics

Sujit Basu et al.
The Anti-angiogenic Action of Dopamine Increases the Efficacies of Anticancer Drugs in Breast and Colon Cancer Preclinical Models

Letters to EditorBack

Peter Bach
Letter to the Editor Regarding Henschke Editorial

Gerard Silvestri
Letter to the editor in response to an editorial written by Claudia Henschke

Claudia Henschke.
Reply to Letters from Bach and Silvestri

Udai Banerji
Biomarkers In Early Clinical Trials: The Committed And The Sceptics.

Bernardo Goulart
Reply to a letter submitted by Banerji et al.

Mark Ratain
Reply to a letter submitted by Banerji et al.

Joost Oudejans
T-cell Response In B-Cell Lymphomas, Favorable or Unfavorable?

Kung-Chao Chang
Reply to Letter from Oudejans

Toshiaki Watanabe
Survival in microsatellite-unstable (MSI) colorectal cancer

Alberto Malesci
Reply to Letter by Watanabe

Merrill Egorin
Population Pharmacokinetc/Pharmacodynamic Modeling of Paclitaxel and Carboplatin in Ovarian Cancer

Markus Joerger
Reply to Letter from Egorin


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Reviews Online Annual Meeting Education Book
Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.